Sun Pharmaceutical Industries Ltd. closed 14.89% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Sun Pharma share price has seen a 10% decline in year-to-date (YTD) performance and an 11% drop over the past six months.

Donald Trump has announced reciprocal tariffs on about 60 countries, including India. He announced 27 per cent reciprocal ...

Sun Pharmaceutical Industries experienced a notable surge in today's session, climbing 2.03% to reach Rs 1786.50. The stock's movement was marked by a significant increase in trading volume ...

Sun Pharma, the largest pharmaceutical company in India, issued one advisory on March 18 cautioning their CFAs and distributors about the rising menace of counterfeit and substandard medicines in the ...

Health Canada sets the bar high, because the new designation means that by doing such testing, qualified labs become part of the pharmaceutical manufacturing chain, where security and documentation ...

Arco Lab will incorporate the NewCo to facilitate the proposed demerger. (Image Credits: Pixabay) Strides Pharma is set to demerge from Arco Labs, a global capability centre, the company said in ...

Purdue Pharma submitted a new bankruptcy plan Tuesday, which will give its creditors more than $7.4 billion in cash—including up to $7 billion in payments from the billionaire Sackler family ...

Mumbai: In a recent BSE filing, Sun Pharmaceutical Industries Limited has informed that TARO Pharmaceuticals Inc., a subsidiary of Sun Pharmaceutical Industries Limited has completed 100 percent ...

LONDON, March 18 (Reuters) - Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars, hoping to avert price spikes on top ...

The impact from 10% tariff on pharma will be manageable with case for pass through by manufacturers, According to BofA. The brokerage picks Apollo Hospitals along with Divi's Labs as the sector ...

The companies behind the product pulls are Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, all three of which hail from India. The drugmakers are recalling seizure treatments ...